Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
18.04. | Aveanna Healthcare Holdings, Inc: Aveanna Announces First Quarter 2024 Earnings Release Date and Conference Call | 1 | GlobeNewswire (USA) | ||
03.04. | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Appointment of Chief Legal Officer and Secretary | 1 | GlobeNewswire (USA) | ||
15.03. | Earnings call: Aveanna Healthcare posts increased Q4 and 2023 revenue | 1 | Investing.com | ||
14.03. | Aveanna Healthcare Holdings, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
14.03. | Aveanna Healthcare Holdings, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
14.03. | Aveanna Healthcare Holdings Inc reports results for the quarter ended in December - Earnings Summary | 1 | Reuters | ||
14.03. | Aveanna Healtcare reports in-line earnings, revenue beat in Q4; Stock up 3.5% | 1 | Investing.com | ||
14.03. | Aveanna Healthcare reports mixed Q4 results; initiates FY24 outlook | 1 | Seeking Alpha | ||
14.03. | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Fourth Quarter 2023 Financial Results and 2024 Outlook | 124 | GlobeNewswire (Europe) | Fourth Quarter Revenue was $478.8 million, a 6.1% increase over the prior year Gross margin increased 15.3% to $148.4 million, compared to Q4 2022 Fourth Quarter Net loss was $25.7 million, compared... ► Artikel lesen | |
14.03. | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
13.03. | A Preview Of Aveanna Healthcare Holdings' Earnings | 1 | Benzinga.com | ||
22.02. | Aveanna Healthcare Holdings, Inc: Aveanna Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call | 1 | GlobeNewswire (USA) | ||
17.01. | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
11.12.23 | Aveanna Healthcare appoints Matt Buckhalter as its CFO | 1 | Seeking Alpha | ||
11.12.23 | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Appointment of Chief Financial Officer | 180 | GlobeNewswire (Europe) | ATLANTA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
11.12.23 | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
30.11.23 | Aveanna Healthcare falls as UBS starts at Sell on leverage | 3 | Seeking Alpha | ||
11.11.23 | Aveanna Healthcare Holdings Inc. (AVAH) Q3 2023 Earnings Call Transcript | 1 | Insider Monkey | ||
09.11.23 | Recap: Aveanna Healthcare Holdings Q3 Earnings | 1 | Benzinga.com | ||
09.11.23 | Aveanna Healthcare Holdings, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ORPEA | 11,854 | -4,82 % | EMEIS PURSUES ITS REFOUNDATION: 2023 Consolidated Financial Results of ORPEA S.A. | Significant improvement in non-financial indicators, with major advances for employees, residents and patients
Health and safety: decline in the work-related accident frequency rate, at 24.8... ► Artikel lesen | |
NANO-X IMAGING | 8,850 | -2,75 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
BUTTERFLY NETWORK | 0,702 | -0,69 % | ThinkSono Ltd: ThinkSono Releases Real-Time DVT AI Training Solution for Butterfly Network's Handheld Ultrasound Devices | LONDON, ENGLAND / ACCESSWIRE / April 23, 2024 / ThinkSono, a pioneering provider of AI-driven medical imaging solutions, is proud to announce the release of ThinkSono AI Training, a deep vein thrombosis... ► Artikel lesen | |
GOODRX | 6,850 | -1,58 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen | |
JOINT CORP | 12,150 | -1,06 % | The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results | ||
CARMAT | 3,150 | -13,93 % | CARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024 | 2023 sales of €2.8 million, i.e. 17 Aeson® implants, including 11 in the last quarter
2024 sales forecast of around €14 million
Active exploration of financing options to extend... ► Artikel lesen | |
HYPERFINE | 0,810 | 0,00 % | Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
PROGYNY | 32,160 | -1,35 % | Progyny, Inc. Announces Third Quarter 2023 Results | Record Quarterly Revenue of $280.9 Million, Reflecting 37% Growth Over the Prior Year PeriodRaises Full Year Revenue and Earnings GuidanceStrong Sales Season Produces 1.3 Million New Covered Lives... ► Artikel lesen | |
MIMEDX | 5,780 | -10,11 % | Mimedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare movers | ||
BIOMERICA | 0,701 | -1,68 % | Biomerica, Inc.: Biomerica Reports Third Quarter 2024 Financial Results | Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst Sales Force Expansion for the Nine Months in Fiscal 2024 InFoods IBS Positive Clinical Data to be Presented... ► Artikel lesen | |
ATRION | 394,00 | +4,79 % | Dividendenbekanntmachungen (14.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN PLC GB00BF8Q6K64 0,073 GBP 0,0853 EUR ABRDN PLC ADR US00108N1000 0,3203 USD 0,2925 EUR ACCO BRANDS CORPORATION US00081T1088 0... ► Artikel lesen | |
ATRICURE | 22,620 | -1,87 % | AtriCure upgraded at Oppenheimer on valuation | ||
CASTLE BIOSCIENCES | 19,010 | -4,28 % | Castle Biosciences Inc.: Presentations at EADO Highlight Potential Impact of Castle Biosciences' DecisionDx-Melanoma and DecisionDx-SCC Tests on the Management of Patients with Skin Cancer | If choosing to use a molecular test to rule-out a sentinel lymph node biopsy (SLNB) in patients diagnosed with melanoma, it is important to show that patients foregoing an SLNB have low risk outcomes... ► Artikel lesen | |
AMWELL | 0,521 | -1,92 % | Amwell Receives Continued Listing Standard Notice From NYSE | Boston, April 04, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of healthcare software as a service, today announced that it received a notice on April 2, 2024 from the New York... ► Artikel lesen | |
TALKSPACE | 2,980 | -2,93 % | Talkspace Announces Third Quarter 2023 Results | B2B payor revenue grew 132% year-over-year 3Q 2023 Operating expenses of $24.0 million, down 30% year-over-year Reduced Net Loss to $4.4 million and Adjusted EBITDA1 loss to $2.8 million, an improvement... ► Artikel lesen |